{"datasets": {"cordis": {"columns": ["inwardCode", "projectTitle", "organisationName", "objective", "contribution", "totalCost", "acronym", "briefTitle", "teaser", "article", "projectUrl", "organizationUrl", "imagePath", "myEuId"], "data": [["5UH", "European Lead Factory", "BioAscent Discovery Ltd", "The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental validation of targets. The concept intends to bridge academic and applied research interests. The European Lead Factory will provide an industry-like small molecule discovery platform to public investigators. It builds on a unique, comprehensive, high-quality compound collection contributed by EFPIA Pparticipants, i.e. the Pharma Consortium Compound Collection totaling over about 300.000 compounds. Screening of these previously safeguarded corporate compound libraries against competitor\u2019s targets and targets from public sources may result in otherwise inaccessible valuable lead structures that could ultimately result in the development of novel treatment options for patients. Academic Participantsa or other eligible bodies (and Contributing Third Parties) will be invited to submit proposals for screening of innovative targets and to suggest the design of new and diverse chemical libraries utilizing novel concepts and strategies. The latter will fuel the generation of a Public Compound Collection that will combine with the Pharma ConsortiumEFPIA Compound Collection to generate the Joint European Compound CollectionLibrary. These public sector contributions will not only provide a constant flow of innovation, but also generate opportunities for future partnerships amongst public Public Participants and private contributors EFPIA Participants on scientific and commercial grounds. EUC2LID\u2019s overarching goal is value creation by screening the Joint European Compound Collection Library against in pPublic and private EFPIA Ttarget Programmes. Based on the successful delivery on its objectives during the IMI funding period, the generation of the high quality Public Compound Collection provides a tangible asset allowing the transition of the European Lead Factory into a novel sustainable business model, facilitating future public-private alliances based on pre-competitive, community-based efforts in early drug research.", 6019879.0, 159043235.0, "EUC\u00b2LID", null, null, null, null, null, null, "fp7_203710_950448196"], ["5UH", "European Lead Factory", "BioCity Scotland Ltd", "The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental validation of targets. The concept intends to bridge academic and applied research interests. The European Lead Factory will provide an industry-like small molecule discovery platform to public investigators. It builds on a unique, comprehensive, high-quality compound collection contributed by EFPIA Pparticipants, i.e. the Pharma Consortium Compound Collection totaling over about 300.000 compounds. Screening of these previously safeguarded corporate compound libraries against competitor\u2019s targets and targets from public sources may result in otherwise inaccessible valuable lead structures that could ultimately result in the development of novel treatment options for patients. Academic Participantsa or other eligible bodies (and Contributing Third Parties) will be invited to submit proposals for screening of innovative targets and to suggest the design of new and diverse chemical libraries utilizing novel concepts and strategies. The latter will fuel the generation of a Public Compound Collection that will combine with the Pharma ConsortiumEFPIA Compound Collection to generate the Joint European Compound CollectionLibrary. These public sector contributions will not only provide a constant flow of innovation, but also generate opportunities for future partnerships amongst public Public Participants and private contributors EFPIA Participants on scientific and commercial grounds. EUC2LID\u2019s overarching goal is value creation by screening the Joint European Compound Collection Library against in pPublic and private EFPIA Ttarget Programmes. Based on the successful delivery on its objectives during the IMI funding period, the generation of the high quality Public Compound Collection provides a tangible asset allowing the transition of the European Lead Factory into a novel sustainable business model, facilitating future public-private alliances based on pre-competitive, community-based efforts in early drug research.", 1799121.0, 159043235.0, "EUC\u00b2LID", null, null, null, null, "http://www.biocity-scotland.co.uk", null, "fp7_203710_953687317"], ["1XA", "FOResight Coordination for Europe", "Efpc ( Uk ) Ltd", "FORCE will examine previous Security foresight studies and horizon-scanning activities in FP7 and elsewhere in Europe and produce, based on this work, a corresponding Intelligent Decision Support System (IDSS), evolvable and scalable with future Foresight research activities conducted in Europe in order to assist policy makers and stakeholders in the Security domain determine expectations about short-term, mid-term and long-term social and technological trends using methodologies and information from past, current and future Foresight research activities. This will allow them to strategically plan for risks related to emerging technologies and social changes in society.\nFORCE activities will include:\n\n\u2022 Examining outputs from Security projects funded in FP7 and other sources in Europe (Internet, studies, journals etc.) related to foresight and Horizon-scanning activities via: Workshops; interviews; collaboration with national and international foresight networks\n\u2022 Producing a Foresight model, scalable and sustainable beyond the end of the project, based on best practice methods and recommendations for future application. This will include:\no Mapping identified risks against foresight methodologies\no Assessing used methods and results regarding strengths and weaknesses\no Identification of  appropriate methods with respect to mix of methods for future research\no Identifying gaps between potential future risks and methods used so far\n\u2022 Developing an Intelligent Decision Support System (IDSS) as an end-user tool that will interface into the Foresight Model. The IDSS will be designed for utilisation by different types of users\n\u2022 Integration of the IDSS with the Foresight model and testing the integrated system using futuristic scenarios\n\u2022 Supporting the visibility and the take up of security research results at stakeholder level, especially focusing on the end users, via dissemination of the Foresight model and corresponding IDSS", 156781.0, 801904.0, "FORCE", null, null, null, "http://www.force-europe.eu/", "http://www.efpconsulting.com", null, "fp7_185500_998859150"], ["1XA", "Advanced Forest Fire Fighting", "Efpc ( Uk ) Ltd", "In recent years, the frequency of large-scale forest fires has increased significantly owing to a number of factors including the effects of climate change, urbanisation, poor landscape management and malevolent acts. These so-called \u201cMega-fires\u201d are particularly destructive and difficult to control with the technologies and systems currently available to fire fighters and emergency agencies. The AF3 project intends  to provide an extraordinary  improvement to the efficiency of current fire-fighting operations and to the protection of human lives, the environment and property by developing innovative technologies and means to ensure a high level of integration between existing and new systems.\nTo reach this objective,  AF3 project focuses on the following areas:\n\u2022 Innovative active countermeasure: implementation of the novel AAFF (Advanced Aerial Fire Fighting) system to accurately and safely disperse extinguishing materials from high altitude by aircrafts and helicopters in any condition: day and night, regardless of weather, smoke and configuration of terrain. It will enable a quick 24H response, minimizing fire duration and damages. The AAFF system can be adapted to a wide variety of aircrafts or helicopters.\n\u2022 Innovative passive countermeasures: fast build-up of preventive defensive lines of  capsules to prevent the spreading of fire from forest to populated areas\n\u2022 Early detection and monitoring: integration and deployment of diverse systems including satellites, aeroplanes, UAVs, and both mobile and stationary ground systems for the early detection of fire and for monitoring the propagation of smoke and toxic clouds.\n\u2022 Integrated crisis management: the innovative AF3 Core Expert Engine will perform overall coordination of all fire fighting missions.\nThe results of AF3 will be validated by intermediate tests during the project, and by a final demonstration with flight tests and drilling exercises carried out simultaneously in Spain, Italy, Greece and Israel.", 451982.0, 15243038.0, "AF3", null, null, null, null, "http://www.efpconsulting.com", null, "fp7_185483_998859150"], ["5FA", "Biotechnological conversion of carbon containing wastes for eco-efficient production of high added value products", "Argent Energy (Uk) Limited", "The applicants propose the development of a sound industrial process that unites the urgently needed solution of industrial waste problems with the creation of essential alternative strategies for polymer industry. This will be done by the biotechnological conversion of waste streams from slaughterhouses, rendering and biodiesel industry towards biodegradable polymeric materials. Slaughterhouse waste is converted towards fatty acid esters (FAMEs, biodiesel). Subsequently those FAME fractions that negatively influence the biodiesel properties as a fuel are biotechnologically converted towards high-value polyhydroxyalkanoate (PHA) biopolymers. This brings together representatives of the envisaged lead users: waste producers from animal processing industry and bio-fuel industry with the polymer industry looking for alternatives technologies. Providing long-term strategies for long-term problems, the project will result in value creation for all players and provide innovative biotechnological approaches for absolutely needed eco-efficient alternatives to contemporary industrial polymer production. The development of this integrated process will be accomplished by beyond the state-of\u2013the-art inputs of microbiology, genetics, biotechnology, chemical engineering, polymer chemistry- and processing and life cycle analysis, combined with feasibility studies for marketing of the final products. The compiled Consortium absolutely conforms to the requirements to fulfill the envisaged project aims. Research will be done in close cooperation between academic and industrial partners. The project activities aim at solving local waste problems affecting the entire EU; the solutions will be developed on local scales, but are meant to be applied to the entire EU and will provide cost-efficient and sound alternatives for polymer industry.", 180277.0, 3182669.0, "ANIMPOL", "Animal waste transformed into plastics", "It is nowadays undisputed that classical plastic materials should be replaced by biocompatible and biodegradable alternatives. To this end, a European study set out to utilise waste material from animal slaughterhouses to synthesise novel plastics.", "Plastics such as polypropylene (PP) or polyethylene (PE) pose an environmental hazard as they elevate the atmospheric carbon dioxide (CO2) concentration during incineration. Ecological considerations therefore necessitate the replacement of these materials with bio-based alternatives like polyhydroxyalkanoates (PHAs).\n\nPHAs constitute a family of biodegradable and biocompatible polyesters with a wide spectrum of potential applications ranging from simple packaging to medical and pharmaceutical materials. Investigators of the EU-funded http://www.animpol.tugraz.at/englisch/eng_home.htm (ANIMPOL) project wished to synthesise PHAs from animal waste derived from slaughterhouses.\n\nANIMPOL had to consider the high cost of PHA production compared to petrochemically produced plastics while avoiding the use of nutritionally important materials to mankind. Given the limitations of current technologies, the consortium selected saturated fat of porcine, bovine and avian origin. These would be exploited to produce fatty acid methyl esters (FAMEs) that can be used as liquid fuel (biodiesel).\n\nA variety of animal waste materials were also used as a carbon source for various microbial PHA producers. The fermentation reaction conditions were extensively investigated to maximise production yield.\n\nExperiments were converted into mathematical models to predict the different types of fermentation performed by the two chosen bacterial species (Cupriavidus necator and Pseudomonas chlororaphis) on different substrates. Significant optimisation was also performed with respect to the PHA recovery techniques.\n\nThe overall streamline process of PHA production from slaughterhouse animal waste was verified to be cost effective, environmentally safe and efficient. Given the public demand for the plastics market to turn to 'green' alternatives, the ANIMPOL approach constitutes a viable strategy for producing biodegradable polymers.", null, "http://www.argentenergy.com", "/docs/results/images/2012-10/58861.jpg", "fp7_93179_992838069"], ["1XA", "Increase Innovation and Research within Security Organisations", "Efpc ( Uk ) Ltd", "Research within Security Organizations by analyzing the main aspects of Innovation Management in security-related operators (end-users), both public and private and not only in terms of quantity but also quality. It is important to assist these organisations to become conscious of the importance of managing Research and Innovation activities.\n\nINSec will establish a framework that will contribute to better performance of the end-user organisations, focusing on their RDI management system as a fundamental method to create knowledge and transform it into economic and social wealth.\n\nBased on security organisations involved as partners in the consortium, 4 different kind of management systems will be specifically addressed, respectively for\n-Rescue Services actors\n-Ministry of Interiors\n-Security Sciences Academies\n-Municipalities\n\nThe implementation of INSec will enable Security organisations to:\n\u2022 Systematise Innovation and Research activities to take advantage of internal and external know-how\n\u2022 Network, exchange experience and learn from the experience for other organisations of the field contributing to the emergence of common needs and common cultures between the security end-users in Europe\n\u2022 Establish goals and objectives that help control operational resources\n\u2022 Improve their organisational image and competitiveness in relation to other national and international competitors\n\u2022Closely monitor technological developments in order to pre-empt the market and identify opportunities for improvement\n\u2022Implement corrective actions based on results emerging from research, development and innovation activities\n\u2022Define training needs and have access ad hoc training\n\u2022Adapt their business models in order to maximise benefits from new technologies\n\u2022Foster innovation culture among employees\n\u2022Establish close relations with technology developers and provide useful feedback\n\u2022Gain the ability to manage internal knowledge\n\u2022Increase the overall perception of what is to innovative", 123323.0, 1273660.0, "INSEC", null, null, null, "http://www.insec-project.eu/en/", "http://www.efpconsulting.com", null, "fp7_103255_998859150"], ["1XA", "Foresight of Evolving Security Threats Posed by Emerging Technologies", "Efpc ( Uk ) Ltd", "'The FESTOS goal is to identify and assess evolving security threats posed by abuse or inadequate use of emerging technologies and new S&T knowledge, and to propose means to reduce their likelihood. Almost all such knowledge can be abused or cause damage through inadequate use. In a free society this should not hinder free generation and exchange of knowledge. As the pace of science-based development accelerates, there is a pressing need for continual scanning of the unfolding technology landscape for potential security threats. Looking ahead to 2030, the foresight study will identify and assess security threats that could stem from future technologies. Robotics, Cognition, New Materials, Nano and Biotechnologies are some of the fields to be scanned. FESTOS will stimulate an 'out of the box' anticipatory thinking and construct threat scenarios by analysing the impact of the identified threats on the background of envisioned \u201csecurity climates\u201d (societal context of security issues). The threat scenarios will be evaluated in terms of their levels of impact and uncertainty. In conjunction with each scenarios critical early-warning indicators will be identified, namely signals that hint at a growing likelihood of specific scenarios and thus provide basis for possible prevention means. Societal issues will be discussed, as well as the controversial issue of controlled dissemination of scientific knowledge in the context of necessary trade-offs between security and the freedom of research and knowledge. Finally policy recommendations will be derived, aiming at novel means of preparedness. Adequate mix of Foresight methods will be employed, e.g. horizon scanning, weak signals analysis, expert surveys, brainstormings, \u201cfutures wheel\u201d, interactive scenario building, STEEPV analysis. Key European stakeholders are addressed in the project\u2019s dissemination plan. The impact of successful foresight in FESTOS could be the initiation of a continuous anticipatory process in Europe.'", 109822.0, 847690.0, "FESTOS", "Emerging technologies - do they pose a security risk?", "While most technologies are developed with good intentions, if they fall into the wrong hands there can be serious consequences. European researchers are investigating the security threats posed by emerging technologies.", "Developments in science and technology can also be used for harmful purposes; computer hackers can cause widespread disruption, while bioterrorists could release a deadly virus into the population.\n\nThe aim of the EU-funded project 'Foresight of evolving security threats posed by emerging technologies' (Festos), which began in 2009, is to identify and assess the security threats posed by the abuse of emerging technologies and propose ways of addressing these threats.\n\nThe project team has carried out horizon-scanning activities to pick up emerging trends and new drivers of change in the next two decades. The team focused in particular on 80 technologies from the fields of robotics, information and communication technologies (ICTs), new materials, nanotechnologies and biotechnologies.\n\nThis analysis was complemented by a global expert survey which uncovered insights regarding the risk and severity of abuse of given technologies. Festos identified three broad categories of potential threat: malicious disruption (i.e. communication jamming); easier access to technologies once reserved for the likes of the military or authorities (i.e. signal interceptors); and misuse of technologies designed for good purposes (i.e. toy robots).\n\nElsewhere, the Festos project embarked on discussions with stakeholders about how to prevent knowledge falling into the wrong hands. This controversial issue involves a trade-off between security, human rights and the freedom to create knowledge.\n\nMeanwhile the Festos team is continuing to work on threat scenarios and related early warning procedures.", "http://www.festos.org", "http://www.efpconsulting.com", "/docs/results/images/2011-01/46101.jpg", "fp7_89978_998859150"], ["1XA", "Trans-national cooperation among ICT National Contact Points", "Efpc ( Uk ) Ltd", "The main objective of Idealist2011 is reinforcing the network of National Contact Points (NCP) for ICT under FP7, by promoting further trans-national cooperation within this network. Thiscooperation will not be reduced to only ICT NCPs but also a degree of collaboration and networking with similar networks in parallel themes (Security, SSH, ENV, Transport, Energy, Health,...etc) especially in the context of joint/coordinated calls will be covered. Special focus is put on helping less experienced NCPs from Member States (MS) and Associated States (AS) to access the know-how accumulated in other countries and to apply it in a locally relevant and efficient manner.Furthermore Idealist2011 aims to address national and cross-border audiences, relying on the NCP network mainly established in the MS and AS at national and regional level, to stimulate, encourage and facilitate the participation in current and future Community ICT research of organisations of all types. Special focus is put on newcomers and SMEs, including organisations from MS, AS and 3rd countries which comprise countries from Eastern Europe Partner Countries (EEPC), Mediterranean Partner Countries (MPC) and selected 3rd coubtries with high technical and economical potential.The activities of Idealist2011 are incremental to the formal NCP responsibilities as they address the international aspects not covered by the nationally funded NCP role. It is built upon:- Experience gained over more than 13 years from the 6 preceding projects covering FP4 to FP7- Strengthening NCP cooperation with support for MS, AS and ICPC- Provision of Training and Twinning for the less experienced NCPs- Provision of partner search quality support- Focused support for SMEs in the ICT sector and for organisations new to the FP- Provision of NCP support for countries with S&T international agreements- Promotion of opportunities and Idealist services ensuring a higher visibility of the NCPs", 130233.0, 3071908.0, "Idealist2011", null, null, null, null, "http://www.efpconsulting.com", null, "fp7_89033_998859150"], ["1XA", "Development of a strategic roadmap towards a large scale demonstration project in European logistics and supply chain security", "Efpc ( Uk ) Ltd", "The goal of the LOGSEC project is to develop a strategic roadmap for a large scale demonstration project in European logistics and supply chain security, characterised by adequate security for the benefit of business and governments, on low time-delay and other cost implications. A broad set of security policies, regulations, standards, technologies, procedural aspects, services, IPR-issues and links to other related projects will be assessed and evaluated during the project in close collaboration between the beneficiaries and business and governmental security end-users. Key technologies and procedural aspects covered by the project include: Container and goods/inventory, authentication, traceability, inspection and monitoring technologies; Risk assessment systems and models; Information transfer systems; Intermodal transport security; Modernisation of customs procedures; Protection of supply chain infrastructure. As the main output, LOGSEC will identify the most relevant/promising research areas and research gaps, which should be addressed in the follow-up demonstration project. The LOGSEC project team consists of organisations with in depth experience in European and global supply chain security research and technology analysis and end-user partners representing a broad set of European shippers and logistics operators and customs administrations. The methodology consists of literature and project reviews; expert interviews; user surveys; user workshops. Background theory will be drawn from supply chain and logistics management; security management; and crime prevention theories. Lessons learnt in other regions, including North and South America and Asia will be exploited during the course of the project. Links to key parallel projects will be established, including demonstrations in Integrated border management (Security) and China-EU secure trade lane (Transportation); related projects with the World Customs Organisation and the World Bank amongst others.", 89970.0, 681750.0, "LOGSEC", null, null, null, "http://www.logsec.org/", "http://www.efpconsulting.com", null, "fp7_94246_998859150"], ["1XA", "Trans-national cooperation among ICT NCPs", "Efpc ( Uk ) Ltd", "The main objective of Idealist2014 is reinforcing the network of National Contact Points (NCP) for ICT under FP7, by promoting further trans-national cooperation within this network. This cooperation will not be reduced to only ICT NCPs but also a degree of collaboration and networking with similar networks in parallel themes (Security, SSH, ENV, Transport, Energy, Health,...etc) especially in the context of joint/coordinated or PPP calls will be covered. Special focus is put on helping less experienced NCPs from Member States (MS) and Associated States (AS) to access the know-how accumulated in other countries and to apply it in a locally relevant and efficient manner. Furthermore Idealist2014 aims to address national and cross-border audiences, relying on the NCP network mainly established in the MS and AS at national and regional level, to stimulate, encourage and facilitate the participation in current and future Community ICT research of organisations of all types. Special focus is put on newcomers and SMEs, including organisations from MS, AS and ICPCs which comprise countries from Eastern European Partner Countries (EEPC), Mediterranean Partner Countries (MPC) and selected ICPCs with high technical and economical potential.The activities of Idealist2014 are incremental to the formal NCP responsibilities as they address the international aspects not covered by the nationally funded NCP role. It is built upon:-Experience gained over more than 15 years from the 7 preceding projects covering FP4 to FP7 and now the transition to FP8-Strengthening NCP cooperation with support for MS, AS and ICPCs-Provision of Training and Twinning for less experienced NCPs-Provision of partner search, pre- and full proposal quality support-Focused support  for SMEs in the ICT sector and for organisations new to the FP-Provision of NCP support for countries with S&T international agreements-Promotion of opportunities and Idealist services ensuring a higher NCP visibility", 190028.0, 3946215.0, "Idealist2014", null, null, null, null, "http://www.efpconsulting.com", null, "fp7_100770_998859150"], ["5UH", "EU Training Network on Novel Targets and Methods in Atrial Fibrillation", "Clyde Biosciences Limited", "The AFib-TrainNet consortium will enable promising young scientists to become excellent research leaders of the future, capable of fighting the challenges that Atrial Fibrillation (AF) presents to the European population. AF is the most common sustained cardiac arrhythmia, occurring in between 1-2% of the general population. More than 6 million Europeans suffer from this arrhythmia and its prevalence is expected to increase by more than two-fold during the next 40 years due to increased life expectancy. Thus, AF is said to assume epidemic proportions. Current options for pharmacological therapy are limited by both low efficacy and side effects, including life\u2010threatening ventricular arrhythmias and severe extra-cardiac toxicities.\nA very limited number of novel AF drug therapies have been introduced in the last 20 years. This imbalance reflects a gap in understanding in both how AF develops and how it can be treated, which thereby limits the development of new medicines. Our ambition with the AFib-TrainNet is to fill this gap by producing new knowledge, leading to critical insight into origins and mechanisms of sustenance of atrial fibrillation. We will accomplish this by developing novel experimental and computational models recapitulating human AF, and employing these models on two very promising atrial biological targets. Experimental models will be instrumental in improving the understanding AF\u2019s underlying mechanisms, and will, along with clinical data, inform state-of-the-art computational models of human atrial electrophysiology. These new tools will permit fresh insight into the molecular, cellular and electrical mechanisms involved in the progression of healthy atria into an AF state. Our endeavor will deliver results which can be leveraged by the pharmaceutical industry to target AF drug development, and the work accomplished in AFib-TrainNet will thus constitute a beacon in the search for new AF medicine.", 231017.0, 3466869.0, "AFib-TrainNet", null, null, null, null, null, null, "h2020_198285_942753186"], ["5UH", "Bio-orthogonal catalysis for cancer therapy", "Biogelx Limited", "THERACAT is an international and multidisciplinary consortium aiming at the training of 13 ESRs on the innovative topic of novel bio-orthogonal catalysis-based tools for cancer therapy. This ETN comprises 6 academic partners, 3 industrial partners active in the pharmaceutical market (1 large pharmaceutical company, Teva, and 2 SMEs, BiogelX and Tagworks) and 3 partners with focus on science communication (Cancer research UK), gender and minorities (UAB-Observatory for Equality) and management and entrepreneurship (ESADE business school). The combination of academic, private and society-involved organisations will provide a broad training for the 13 ESRs recruited, equipping them with the necessary skills to succeed as scientists, industrial researchers and entrepreneurs. \nThe development of novel cancer therapies is a major challenge for academic research and pharmaceutical industries. THERACAT aims to establish a training programme focused on the development of THERApeutic CATalysts. In this strategy, materials bearing a catalytic unit are delivered to the tumour and subsequently non-active prodrugs are administered. The prodrugs are non-toxic and therefore generate limited side effects. Only at the tumour site the catalytic particles convert the prodrugs into active compounds that generate a therapeutic effect. This approach presents several advantages on the classical drug delivery paradigm including limited side effects and prolonged efficacy. \nThis multidisciplinary research programme will be the setting for the training of 13 ESRs. The combination of the research expertise, the cutting-edge facilities and the complementary skills present in the consortium holds a great promise for the advancement of their careers, as well as of the knowledge of catalysis-based anticancer therapies and the development of marketable technologies and products.", 238115.0, 2947802.0, "THERACAT", null, null, null, null, null, null, "h2020_215989_941323309"], ["5FA", "Demonstration of new, challenging and high FFA waste oil and fat feedstock in biodiesel process with improved costs, conversion and high fuel quality", "Argent Energy (Uk) Limited", "BioDie2020 will recover unconventional, degraded waste oils & fats, notably from Water Company infrastructures, and demonstrate the conversion of these wastes as a sustainable feedstock for biodiesel production. This break-through & beneficial pathway will maximise the use of waste oils & fats on a large scale for the 1st time on the biodiesel market, leading to lower transport carbon emissions. BioDie2020 FTI combines 5 top EU players in an agile & direct value-chain, working on this industry-wide milestone which will improve costs & conversion, achieving high fuel quality. Project coordinator Argent (UK, INDUS), a forward-thinking biofuel leader, will thus demonstrate biodiesel production in a closed-loop business model. 2 key process improvements will go from TRL6 to 7 at Argent\u2019s biodiesel plant (site at Stanlow, UK): i) biofuel technology provider BDI (Austria, SME) will deliver Sulphur reduction in the biodiesel process; ii) microwave technology provider LJMU (UK, Uni) will integrate their bespoke microwave unit to improve pre-treatment of challenging feedstocks. Stagecoach (UK, INDUS), a leading EU captive bus fleet service provider, will perform field trials of final biodiesel. Quantis (France, SME), an ambitious EU SME will perform LCA & LCC analysis of the overall process, ensuring sustainability objectives are achieved. BioDie2020 partners own IP on each technical brick, giving pathways to market & business opportunities. Argent will save ~\u20ac5 million/year on feedstock costs, improving ROIC from 12% to 18% by 2019. Demo of BDI\u2019s new process will confer a competitive edge on the retrofit market, giving them a ~25% sales increase by 2020. BioDie2020 will deliver 17 direct jobs and ~100 indirect jobs created or sustained in the EU by 2020. Argent\u2019s ultimate aim is to invest in biofuel deployment via this reproducible waste-to-biodiesel plant (embedded in a closed-loop business model) with market replication by 2020 via commissioning or acquisition & retrofit.", 695476.0, 2467747.0, "BioDie2020", null, null, null, null, "http://www.argentenergy.com", null, "h2020_207483_992838069"], ["4WQ", "Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer", "Tc Biopharm Limited", "Europe is experiencing an unprecedented cancer epidemic, driven by our ageing population. Traditional cancer treatments such as surgery, chemotherapy and radiation therapy have demonstrated very limited efficacy for patients with late-stage disease and often cause considerable side effects.\nCell therapies are the next breakthrough in oncology, but autologous cells must be harvested from each patient, expanded for several weeks in vitro and re-administered to the same patient while hospitalized. \nTCB, a Scottish SME, brings the first allogeneic gamma delta T cell therapy (OmnImmune) where T cells harvested from healthy donors are used to treat multiple recipients. \nOmnImmune represents a truly disruptive, step-changing approach to the treatment of a wide variety of cancers. It has the potential to be manufactured for large market segments at a lower cost than competitors and provide valuable increases to the quality of life of life.\nOmnImmune will provide next generation cancer treatment at 20% of the cost of any other cell therapy, saving \u20ac24Bn per year for 60,000 patients treated.\nOmnImmune\u2019s unique characteristics make it a truly disruptive treatment solution for patients and clinicians:\nMultifunctional treatment solution: available to all cancer patients, regardless of their disease grade or immune status.\nPredicted high safety profile: minimal side-effects based on clinical data from trials of autologous GDT cells (to be confirmed in dose-escalation clinical trial).\nEase of use and lower cost: frozen dose-ready units available for immediate patient administration.\nThe SME Instrument funding will accelerate the development of the OmnImmune therapy and reduce its time to market from 10 years to 6 years. This will allow OmnImmune to reach the market by 2024.", 3460485.0, 3460485.0, "OmnImmune", null, null, null, null, null, null, "h2020_213204_923581621"], ["1XA", "The HUB for boosting the Responsibility and inclusiveness of ICT enabled Research and Innovation through constructive interactions with SSH research", "Efpc ( Uk ) Ltd", "The long term strategic objective of HubIT is to contribute to the high level of European research and innovation and ensure that H2020 funded and further ICT related innovation is responsible, inclusive and aimed at reversing inequalities.\n\nThe direct objective of HubIT is to build a hub that will activate and improve constructive and co-creating interactions between SSH and ICT disciplines in developing and implementing a shared vision of inclusive \n\nHubIT will activate constructive interactions between the stakeholders forming the RRI-SSH eco-system via various network and engagement activities embedded intro the WP structure, that have the overall goal of developing a tangible European Framework Model for implementing responsible and inclusive ICT research and innovation. The Framework Model is a comprehensive set of jointly developed and used definitions, guidelines and tools for enforcing RRI and SSH issues in ICT research and innovation:\n\u2022 The concept of responsible R&I\n\u2022 Matrix of the key challenges\n\u2022 Tool for assessment of RRI and SSH perspectives in ICT within an organisation\n\u2022 Guidelines for responsible ICT R&I informed by SSH\n\u2022 Best Practice Repository\n\u2022 Fact Sheets and Policy briefs\n\u2022 Key measurable success indicators \n\u2022 Policy Recommendations\n\u2022 Virtual Matching Catalogue\n\u2022 HubIT exploitation plan \n\nThe mechanisms for network building, engagement and awareness rising embedded in the WP structure are:\n\u2022 Advisory Board workshops\n\u2022 Expert Group workshops\n\u2022 Community building and knowledge sharing \u2013 national network events, thematic workshops, policy, SSH researchers and ICT industries workshops\n\u2022 Practical collaborations and experimentation - Common Ground Camps, Interactive ICT Labs, Inclusive Hackathons\nIn total 35 network activities are implemented and in total 1140 participants. HubIT online platform will be the interactive environment, where the project tools and services can be accessed in modular, visually attractive and dynamic way.", 213718.0, 2623435.0, "HubIT", null, null, null, null, "http://www.efpconsulting.com", null, "h2020_211652_998859150"], ["5UH", "Intelligent Freshtag Labels for Supply Chain Temperature Monitoring", "Insignia Technologies Limited", "Insignia Technologies has developed and run initial testing on time and temperature sensitive labels that are used to reduce food waste and monitor temperature abuse within the supply chain. To build on the small scale testing that has been carried out thus far, Insignia proposes to run a Phase 1 project with the aim of producing further prototype Freshtag labels that will be used in live trials with customers in Europe including Autogrill, Sodexo and The Co-Operative. Define optimal requirements from the test customers, attend FachPack in Nuremberg in September 2016 to showcase the technology, research developing markets and use all of the results and data gathered to structure a business plan that moves forward to large scale trials with a range of customers as part of a Phase 2 project.", 41000.0, 58571.0, "IFLFSCTM", null, null, null, null, null, null, "h2020_204341_920570547"], ["1XA", "Transnational Cooperation among ICT NCPs", "Efpc ( Uk ) Ltd", "The main objective of Idealist2018 is reinforcing the network of National Contact Points (NCP) for LEIT ICT under Horizon2020, by promoting further trans-national cooperation within this network. This cooperation will also include collaboration and networking with similar networks in parallel themes (Security, ENV, Transport, Energy, Health,\u2026etc) especially in the context of joint/coordinated or PPP calls. \n\nSpecial focus is put on helping less experienced NCPs from Member States (MS) and Associated Countries (AC) to access the know-how accumulated in other countries and to apply it in a locally relevant and efficient manner.\n\nFurthermore Idealist2018 aims to address national and cross-border audiences, relying on the NCP network mainly established in the MS and AC at national and regional level, to stimulate, encourage and facilitate the participation of current and future ICT research stakeholders in ERA. Special focus is put on newcomers and SMEs, including organisations from MS, AC and third Countries.\n\nThe activities of Idealist2014 are incremental to the formal NCP responsibilities as they address the international aspects not covered by the nationally funded NCP role. It is built upon:\n-Experience gained over more than 15 years from the 8 preceding projects covering FP4 to FP7 and now the transition to H2020\n-Strengthening NCP cooperation with support for MS, AC and third Countries\n-Provision of Training and Twinning for less experienced NCPs \n-Provision of partner search, pre- and full proposal quality support\n-Focused support for SMEs in the ICT sector and for organisations new to H2020\n-Provision of NCP support for countries with S&T international agreements \n-Promotion of opportunities and Idealist services ensuring a higher NCP visibility", 194878.0, 3484689.0, "Idealist2018", null, null, null, null, "http://www.efpconsulting.com", null, "h2020_194295_998859150"]]}, "fts": {"columns": ["inwardCode", "beneficiary", "amount", "budgetLineNameAndNumber", "myEuId", "year"], "data": [["4WQ", "TC BIOPHARM LIMITED", 3451503.0, "Improving lifelong health and well-being (08.02.03.01)", "fts_2017_10597", 2017], ["1XA", "EFPC (UK) LTD*", 213156.0, "Fostering inclusive, innovative and reflective European societies (09.04.03.02)", "fts_2017_13023", 2017]]}}, "outwardCode": "ML1"}